Nephrogenic Fibrosing Dermopathy and High-Dose Erythropoietin Therapy
- 1 August 2006
- journal article
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 145 (3) , 234-235
- https://doi.org/10.7326/0003-4819-145-3-200608010-00021
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Antibody-mediated pure red cell aplasia (PRCA): epidemiology, immunogenicity and risksNephrology Dialysis Transplantation, 2005
- Nephrogenic fibrosing dermopathy: the first 6 yearsCurrent Opinion in Rheumatology, 2003
- A Novel Role for Erythropoietin During Fibrin-Induced Wound-Healing ResponseThe American Journal of Pathology, 2003
- What Nephrogenic Fibrosing Dermopathy Might BeArchives of Dermatology, 2003
- Hyporesponsiveness to recombinant human erythropoietinNephrology Dialysis Transplantation, 2001
- Scleromyxoedema-like cutaneous diseases in renal-dialysis patientsPublished by Elsevier ,2000